Nature Communications (Aug 2020)
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
Abstract
In recent years, hematopoietic stem cells gene editing has emerged as a promising tool to treat blood disorders. Here the authors develop a CRISPR/Cas9-based genome editing strategy that allows the precise correction of Wiskott-Aldrich Syndrome in vitro and in vivo with high efficiency.